Chinese researchers today reported novel triple-reassortant influenza strains in swine, and the viruses carry genes that have been noted in human flu infections, according to a study in Emerging Microbes & Infections.
The US Food and Drug Administration (FDA) approved an additional claim for the cobas Zika test, manufactured by Roche Molecular Diagnostics, the company announced today in a news release. The approval allows the test to be used to screen pooled blood and plasma donations for the Zika virus.
According to Roche, the new application will streamline the screening process of multiple individual blood or plasma donations.
Twelve more people in five states have been sickened with Salmonella from eggs produced by an Indiana farm, bringing the outbreak total to 35 cases in nine states, the Centers for Disease Control and Prevention (CDC) said in an update yesterday.
The Centers for Disease Control and Prevention (CDC) today confirmed 28 new cases of Escherichia coli infections and four newly affected states in an outbreak tied to eating romaine lettuce from the Yuma, Ariz., growing region that has caused higher rates of severe disease than is typically seen with E coli.
Experts agree that the next flu pandemic could well be devastating—and how ill-prepared the world is.
In a speech at the annual meeting of the Massachusetts Medical Society on Apr 27, philanthropist and Microsoft cofounder Bill Gates announced the launch of a $12 million Grand Challenge to speed the development of a universal flu vaccine.
The Trump administration plan to shift oversight of the nation's Strategic National Stockpile (SNS) and its $575 million budget from the Centers for Disease Control and Prevention (CDC) to the Department of Health and Human Services (HHS) Assistant Secretary for Preparedness and Response (ASPR) is set to occur in October, but some observers worry that the plan could impede deployment when supplies are needed and that dec
The US as a whole had a score of 7.1 out of 10 for 2017, nearly a 3% improvement.
The National Institute of Allergy and Infectious Diseases (NIAID) last week announced the launch of two phase 2 clinical trials of a candidate H7N9 influenza vaccine, one to assess different dosages with or without an adjuvant and the second to look at the adjuvanted vaccine's performance alongside a quadrivalent seasonal flu vaccine.
In an update on an ongoing intravenous saline bag shortage, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, said yesterday the situation is improving, and the agency expects that the problems will be resolved well before the next flu season begins.
